Finally, the investigation of the main pathways found altered and associated with LGMDD2 pathology has obvious implications in the design of new therapeutic strategies, not only for this type of muscular dystrophy but also for HIV-1 infection. Here, TNPO3 is linked to muscular dystrophy.